Cite
HARVARD Citation
Song, M. et al. (2022). The advanced lung cancer inflammation index is the optimal inflammatory biomarker of overall survival in patients with lung cancer. Journal of cachexia, sarcopenia and muscle. 13 (5), pp. 2504-2514. [Online].